Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

Andrea Bertotti; Mike F. Burbridge; Stefania Gastaldi; Francesco Galimi; Davide Torti; Enzo Medico; Silvia Giordano; Simona Corso; Gaëlle Rolland-Valognes; Brian P. Lockhart; John A. Hickman; Paolo M. Comoglio; Livio Trusolino

doi:10.1126/scisignal.2000643

Research ArticleCancer Biology

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

Andrea Bertotti¹,
Mike F. Burbridge²,*,
Stefania Gastaldi¹,*,
Francesco Galimi¹,*,
Davide Torti¹,*,
Enzo Medico³,
Silvia Giordano¹,
Simona Corso¹,
Gaëlle Rolland-Valognes⁴,
Brian P. Lockhart⁴,
John A. Hickman²,
Paolo M. Comoglio¹,^†, and
Livio Trusolino¹,^†

¹Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.
²Cancer Research and Drug Discovery, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France.
³Laboratory of Functional Genomics, The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.
⁴Division of Molecular Pharmacology and Pathophysiology, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France.

↵†To whom correspondence should be addressed. E-mail: livio.trusolino{at}ircc.it (L.T.) and paolo.comoglio{at}ircc.it (P.M.C.)

↵* These authors contributed equally to this work.

See allHide authors and affiliations

Science Signaling 08 Dec 2009:
Vol. 2, Issue 100, pp. ra80
DOI: 10.1126/scisignal.2000643

Andrea Bertotti

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mike F. Burbridge

2Cancer Research and Drug Discovery, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stefania Gastaldi

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francesco Galimi

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Davide Torti

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Enzo Medico

3Laboratory of Functional Genomics, The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Silvia Giordano

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Simona Corso

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gaëlle Rolland-Valognes

4Division of Molecular Pharmacology and Pathophysiology, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brian P. Lockhart

4Division of Molecular Pharmacology and Pathophysiology, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John A. Hickman

2Cancer Research and Drug Discovery, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paolo M. Comoglio

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: livio.trusolino@ircc.it paolo.comoglio@ircc.it

Livio Trusolino

1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: livio.trusolino@ircc.it paolo.comoglio@ircc.it

Article
Figures & Data
Info & Metrics
eLetters
PDF

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Submit a Response to This Article

Compose eLetter

Title

Contents

More information about text formats

Plain text

Plain text
No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First name and middle name First or given name, e.g. 'Peter'. Last Name Your last, or family, name, e.g. 'MacMoody'. Email Your email address, e.g. higgs-boson@gmail.com Role / Occupation Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests?

Yes

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

No eLetters have been published for this article.

View Full Text

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

Plain text

Vertical Tabs

Science Signaling

Article Tools